SCHEMBL29501439

SCHEMBL29501439

Fc1cc(F)cc(Nc2cc(N3CCC(N4CCc5ccccc5C4)CC3)ncn2)c1

nearest known ligand 0.48

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 1/20 0.48
CHRM4 P08173 10/20 0.42
CHRM2 P08172 2/20 0.41
CHRM5 P08912 2/20 0.41
CHRM1 P11229 2/20 0.41
CHRM3 P20309 2/20 0.41
ADRA1A P35348 3/20 0.40
CXCR3 P49682 1/20 0.40
HRH4 Q9H3N8 1/20 0.40
SMO Q99835 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26248704 1.00 SCN9A (0.48) SCN9ACHRM4CHRM2CHRM5CHRM1
SCHEMBL29501415 0.92 SCN9A (0.53) SCN9ACHRM4CHRM2CHRM5CHRM1
SCHEMBL29501346 0.92 SCN9A (0.48) SCN9ACHRM4CHRM2CHRM5CHRM1
SCHEMBL26248210 0.92 SCN9A (0.48) SCN9ACHRM4CHRM2CHRM5CHRM1
SCHEMBL26248733 0.91 SCN9A (0.47) SCN9ACHRM4CHRM2CHRM5CHRM1
SCHEMBL26248126 0.90 SCN9A (0.53) SCN9ACHRM4CHRM2CHRM5CHRM1
SCHEMBL29501470 0.89 SCN9A (0.50) SCN9ACHRM4CHRM2CHRM5CHRM1
SCHEMBL26249666 0.89 SCN9A (0.50) SCN9ACHRM4CHRM2CHRM5CHRM1
SCHEMBL29501447 0.88 SCN9A (0.48) SCN9ACHRM4CHRM2CHRM5CHRM1
SCHEMBL26248714 0.88 SCN9A (0.48) SCN9ACHRM4CHRM2CHRM5CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116113626-A Compound with anti-tumor activity and application thereof 上海翊石医药科技有限公司 2023-05-12 CN disclosed
WO-2022048631-A1 COMPOUND HAVING ANTITUMOR ACTIVITY AND USE THEREOF 上海翊石医药科技有限公司 2022-03-10 WO disclosed